Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02694822
Title AGEN-1884, an Anti-CTLA-4 Antibody, in Advanced Solid Cancers
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Agenus Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91010 United States Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Rocky Mountain Cancer Center Denver Colorado 80218 United States Details
University of Miami Miller School of Medicine Miami Florida 33136 United States Details
Comprehensive Cancer Center of Northwestern University Chicago Illinois 60611 United States Details
Ochsner Cancer Institute New Orleans Louisiana 70121 United States Details
Atlantic Health System/Morristown Medical Center Morristown New Jersey 07962 United States Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Texas Oncology - Austin Midtown Austin Texas 78705 United States Details
Texas Oncology, Tyler Texas Tyler Texas 75702 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field